Andrew Mackinnon’s Post

View profile for Andrew Mackinnon, graphic

Driving the future of modern, digital clinical trials @ Medable

An often quoted obstacle to the adoption of eConsent is the view of sites, the challenges around training site users, and how to place a new technology within existing site processes. The case study detailed here shows how the Medable team partnered closely with US Renal Care on a challenging consent requirement, providing our standard training modules and delivering a live solution within a matter of 2 weeks, that was expanded to include US Spanish within just another 2 weeks. If you're interested in understanding more about this, and how we can support adoption within your trials then please reach out. #medable #econsent #digitaltrials #remoteconsent

View organization page for Medable, Inc, graphic

109,980 followers

TRIAL NEWS ⚛️: Medable's Total Consent solution achieved a 75% adoption rate when deployed in an elderly patient population in U.S. Renal Care's (USRC) investigator-initiated trial. The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. Learn more here: https://lnkd.in/et3RMWsN ________ Michelle Longmire, Tim Smith, Alison Holland, Andrew Mackinnon, Jason Rothbart, Pamela Tenaerts, MD, MBA #clinicaltrials #clinicalresearch #healthcare #patientcare

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial | Medable

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial | Medable

medable.com

To view or add a comment, sign in

Explore topics